דף הבית >> חברי הסגל >> ד”ר שמואל קלנג

ד”ר שמואל קלנג

סגל פנים, החוג לדימות רפואי והחוג לניהל מערכות בריאות

shmuel klang

 

shmuelk@mishpat.ac.il

השכלה

Ph.D בפרמקולוגיה ורוקחות, M.H.A במנהל מערכות בריאות

 

תחומי הוראה והתמחויות

החוג  לדימות: ביולוגיה של התא, אימונולוגיה, פיזיולוגיה , פרמקולוגיה.

החוג ניהול מערכות בריאות: תרופות ביולוגיות ואימונותרפיה.

פרסומים נבחרים

  1. Elbaz, A. Zeevi S. Klang S. Benita. Positively-charged submicron emulsions- a new type of colloidal drugs carrier. Int. J. Pharm. 96 R1-R6. 1993

(IF 0.898 Rank=100/157 in, Pharmacology and Pharmacy, Q3)

  1. Zeevi, S. Klang, V. Alard F. Brossard S. Benita. The desighn and characterization of positively-charged submicron emulsion containing a sunscreen agent. Int. J. Pharm. 108, 57-68. 1994

(IF 0.898 Rank=100/157 in, Pharmacology and Pharmacy, Q3)

  1. +Klang SH, Benita S. The role of Stearylamine in the design of a positively charged submicron emulsion of piroxicam. Bulletin Technique Gattefosse. Vol 87 1994.

(IF and Rank are not available for 1994)

  1. +Klang SH, Frucht-Pery J, Hoffman A, Benita S. Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle. Journal of pharmacy and pharmacology. Dec;46(12):986-93: 1994.

(IF 2.39 Rank=150/267 in, Pharmacology & Pharmacy , Q3)

  1. +Klang SH, Baszkin A., Benita S. The stability of Piroxicam incorporated in a positively-charged submicron emulsion for ocular administration. J. Pharm. 132, 33-44 1996.

(IF 0.898 Rank=100/157 in, Pharmacology and Pharmacy, Q3)

  1. +Klang SH, Siganos CS, Benita S, Frucht-Pery J. Evaluation of a positively charged submicron emulsion of piroxicam on the rabbit corneum healing process following alkali burn. Journal of controlled release: official journal of the Controlled Release Society. 1999 Jan 4;57(1):19-27.

(IF 2.059, Rank=43/175 in, Pharmaceutical Sciences, Q1)

  1. +Klang SH, Abdulrazik M, Benita S. Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution. Pharmaceutical development and technology. 2000;5(4):521-32.

(IF 0.881, Rank=194/492 in, Pharmacology & Pharmacy, Q1)

  1. Giveon SM, Liberman N, Klang SH, Kahan E. A survey of primary care physicians’ perceptions of their patients’ use of complementary medicine. Complementary therapies in medicine. 2003 Dec;11(4):254-60.

(IF 1.194, Rank=2/9 in, Integrative & Complementary Medicine, Q1)

  1. Giveon SM, Liberman N, Klang SH, Kahan E. Are people who use “natural drugs” aware of their potentially harmful side effects and reporting to family physician? Patient education and counseling. 2004 Apr;53(1):5-11.

(IF 1.429, Rank=45/93 in, Public Health, Q2)

  1. Hammerman A, Dreiher J, Klang SH, Munitz H, Cohen AD, Goldfracht M. Antipsychotics and diabetes: an age-related association. Annals of pharmacotherapy. 2008 Sep;42(9):1316-22.

(IF 2.305, Rank=109/2199 in, Pharmacology & Pharmacy, Q2)

  1. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang SH, Niv Y. Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants. American journal of gastroenterology. 2009 Apr;104(4):933-8.

(IF 6.324, Rank=3/126 in, Gastrology &Hepatology, Q1)

  1. +Klang SH, Hammerman A, Liebermann N, Efrat N, Doberne J, Hornberger J. Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2010 Jun-Jul;13(4):381-7.

(IF 2.342, Rank=16/72  in, Health Care Sciences & Services, Q1)

  1. Nitzan O, Low M, Lavi I, Hammerman A, Klang SH, Raz R. Variability in outpatient antimicrobial consumption in Israel. Infection. 2010 Feb;38(1):12-8.

(IF 2.244, Rank=38/58 in, Infectious Disease, Q3)

  1. Brezis M, Tomer R, Klang SH, Hammerman A. [Why do good drugs disappear?]. Harefuah. 2010 Oct;149(10):652-5, 683. Hebrew.

(IF 0.149, Rank=5178/7041 in, Medicine, Q4)

  1. Segal G, Liebermann N, Klang SH, Siegelmann-Daniel N, Beit-Or A, Klien B, Shoushan-Gutman L. [Identification of K-RAS mutations in colorectal cancer patients in Israel]. Harefuah. 2011 May;150(5):447-50, 491. Hebrew.

(IF 0.203, Rank=5175/7229 in, Medicine, Q4)

  1. Stemmer SM, Klang SH, Ben-Baruch N, Geffen DB, Steiner M, Soussan-Gutman L, Merling S, Svedman C, Rizel S, Lieberman N. The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients. Breast cancer research and treatment. 2013 Jul;140(1):83-92.

(IF 4.198, Rank=49/203 in, Oncology, Q1)

  1. +Klang SH, Ben-Amnon Y, Cohen Y, Barak Y. Community pharmacists’ support improves antidepressant adherence in the community. International clinical psychopharmacology. 2015 Nov;30(6):316-9.

(IF 2.415, Rank=122/255 in, Pharmacology & Pharmacy, Q2)

  1. Stemmer SM, Steiner M, Rizel S, Soussan-Gutman L, Ben-Baruch N, Bareket-Samish A, Geffen DB, Nisenbaum B, Isaacs K, Fried G, Rosengarten O, Uziely B, Svedman C, McCullough D, Maddala T, Klang SH, Zidan J, Ryvo L, Kaufman B, Evron E, Karminsky N, Goldberg H, Shak S, Liebermann N. Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry. NPJ breast cancer. 2017 Sep 8; 3:33. DOI: 10.1038/s41523-017-0034-6.

(IF 3.703, Rank=364/369 in, Oncology)

  1. *+Klang Shmuel, Megiddo Dalia, Lapidot Tair & Naparstek Yaakov. Low pH Hypromellose   (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post massgathering event at a highly endemic community: An observational prospective open label user survey. Expert Review of Anti-infective Therapy. Posted online: 3.2021. DOI: 10.1080/14787210.2021.1908127

(IF 2.415, Rank=122/255 in Pharmacology & Pharmacy, Q2)

  1. *+Klang Shmuel, Shahar Merling, Sigal Rosenberg, Galit Borchuk and Meir Pugatch. Utilization of Health Resources During the Coronavirus Pandemic in Israel: Meuhedet Health Services’ Real Data Analysis and Future Conclusions. Electronic Publication Date: March 29, 2023.

DOI: 10.2174/18749445-v16-230221-2022-16

(JCR IF= N/A, SJR 2023= 0.255, R 2023= Public Health, Environmental and Occupational Health 478/715 Q3; Community and Home Care 26/44 Q3; Health (social science) 259/390 Q3)

  1. Shai Moshel, Shmeul Klang, Revital Nikname, Katy Bar Shalom Dov Albukrek ,Galia Zacay. Automated versus Manual Prior Authorization for Diabetes Mellitus Drugs: A retrospective study from Israel. Accepted for publication. DIGITAL HEALTH Volume 9, January-December 2023

(JCR IF 2023= 2.9, R 2023= PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 129/408 Q2)

  1. Areen Khateeb Alabbasi, Shai Cohen, Manfred S. Green, Meir Preis, Shmuel Klang, Shuli Brammli-Greenberg.  Assessing the Impact of a Designated Pharmacist Intervention on Drug Treatment Costs and Technical Efficiency in the Hemato-Oncology Outpatient Clinic. Value in Health Regional Issues.

Volume 44, November 2024, 101034. https://doi.org/10.1016/j.vhri.2024.101034

(JCR IF 2024= 1.5, R 2024= HEALTH CARE SCIENCES & SERVICES 136/188 Q3, SJR 2024= 0.626, R 2024= Economics, Econometrics and Finance (miscellaneous) 111/514 Q1; Pharmacology, Toxicology and Pharmaceutics (miscellaneous) 30/129 Q1)

  1. Areen Khateeb Alabbasi, Manfred S. Green, Shuli Brammli-Greenberg, Mouna Ballan Haj, Meir Preis, Naama Schwartz, Ophir Lavon, Shmuel Klang, and Shai Cohen. The Role of a Designated Pharmacist in Reducing the Rate of Adverse Drug Reactions and Preventing Potential Medication Errors in Hemato-oncology Care: A Randomized Controlled Trial. JCO Oncology Practice. 1.8.2025 JCO Oncology Practice (JCO OP), https://doi.org/10.1200/OP-25-00158

(JCR IF 2024= 4.7, R 2024= ONCOLOGY 77/328 Q1)